CGRP Modulates Orofacial Pain through Mediating Neuron-Glia Crosstalk

Area of Science:

• Neuroscience
• Pain Research
• Cellular Biology

Background:

• Calcitonin gene-related peptide (CGRP) is implicated in orofacial pain modulation.
• Neuron-glia interactions are increasingly recognized in pain signaling pathways.

Purpose of the Study:

• To investigate the mechanisms of CGRP-mediated neuron-glia crosstalk in orofacial pain.
• To elucidate the role of CGRP and nitric oxide in trigeminal pain signaling.

Main Methods:

• Orofacial pain model induced by ligating closed-coil springs.
• Primary culture of trigeminal neurons and satellite glial cells (SGCs).
• Analysis of gene and protein expression (immunostaining, PCR, Western blot).
• Assessment of orofacial pain using the rat grimace scale.

Main Results:

• CGRP expression increased in trigeminal neurons and SGCs during orofacial pain.
• CGRP administration exacerbated pain; olcegepant alleviated pain.
• CGRP knockdown reduced CGRP levels and alleviated pain.
• CGRP upregulated inducible nitric oxide synthase (iNOS) in SGCs via the p38 pathway.
• Nitric oxide donor (L-arginine) enhanced pain by increasing CGRP expression.
• L-arginine increased CGRP expression in neurons via N-type calcium channels.

Conclusions:

• CGRP modulates orofacial pain by upregulating nitric oxide production in SGCs.
• Nitric oxide stimulates CGRP expression in neurons through N-type calcium channels.
• This establishes a positive-feedback loop of CGRP-mediated neuron-glia crosstalk in orofacial pain.